Calif. molecular Dx firm could bring in $1.9M from stock sale

09/23/2013 | GenomeWeb Daily News (free registration)

Response Genetics hopes to secure $1.9 million in a direct offering of shares. The Los Angeles molecular diagnostics company will use the money to expedite integration of the Tissue of Origin assay it acquired from Pathwork Diagnostics. The test has FDA clearance for identifying undifferentiated, poorly differentiated and metastatic cancers.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT